Tag Archives: AMRN

Thursday’s Midday Stock Update: Keryx Biopharma (KERX), Amedica (AMDA), Gastar Exploration (GST), Amarin (AMRN), Frontier Communications Corporation (FTR)

So far Thursday, June 28, NASDAQ is up 0.87% and the S&P is up 0.8%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Keryx Biopharma (NASDAQ:KERX), Amedica (NASDAQ:AMDA), Gastar Exploration (NYSE MKT:GST), Amarin

Thursday’s Midday Movers: Keryx Biopharma (KERX), Amedica (AMDA), Gastar Exploration (GST), American Green Inc (ERBB), Amarin (AMRN)

So far Thursday, June 28, NASDAQ is up 0.87% and the S&P is up 0.8%. Here are this morning’s most active stocks: Keryx Biopharma (NASDAQ:KERX), Amedica (NASDAQ:AMDA), Gastar Exploration (NYSE MKT:GST), American Green Inc (Other OTC:ERBB) and Amarin (NASDAQ:AMRN). Keryx

Cantor Fitzgerald Reaffirms Their Buy Rating on Amarin

In a report released today, Louise Chen from Cantor Fitzgerald maintained a Buy rating on Amarin (NASDAQ: AMRN), with a price target of $10. The company’s shares closed yesterday at $3.48. Chen observed: “We reaffirm our OW rating and believe

Cantor Fitzgerald Thinks Amarin’s Stock is Going to Recover

Cantor Fitzgerald analyst Louise Chen maintained a Buy rating on Amarin (NASDAQ: AMRN) today and set a price target of $10. The company’s shares closed yesterday at $3.10, close to its 52-week low of $2.82. Chen wrote: “Amarin announced the

Amarin Gets a Buy Rating from Cantor Fitzgerald

In a report released today, Louise Chen from Cantor Fitzgerald maintained a Buy rating on Amarin (NASDAQ: AMRN), with a price target of $10. The company’s shares closed yesterday at $2.93, close to its 52-week low of $2.82. Chen observed:

Cantor Fitzgerald Maintains Their Buy Rating on Amarin

In a report released today, Louise Chen from Cantor Fitzgerald maintained a Buy rating on Amarin (NASDAQ: AMRN), with a price target of $10. The company’s shares opened today at $3.66. Chen commented: “We like AMRN shares. The stock is